PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
0.9606
-0.0594 (-5.82%)
At close: Dec 5, 2025, 4:00 PM EST
0.9200
-0.0406 (-4.23%)
After-hours: Dec 5, 2025, 7:54 PM EST
PainReform Market Cap
PainReform has a market cap or net worth of $1.93 million as of December 5, 2025. Its market cap has decreased by -37.96% in one year.
Market Cap
1.93M
Enterprise Value
-1.49M
1-Year Change
-37.96%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $1.93M, a decrease of -97.24%. That is a compound annual growth rate of -49.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.93M | -34.12% |
| Dec 31, 2024 | 2.94M | -31.51% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
| Sep 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |